SUBSCRIBE
SUBSCRIBE

Lung cancer

AstraZeneca's sign on its office in California
FDA
AstraZeneca Expands Tagrisso’s NSCLC Label, FDA Allows Use with Chemo
The regulator’s approval means AstraZeneca’s Tagrisso can now be used in combination with chemotherapy for locally advanced or metastatic EGFR-mutated non-small cell lung cancer patients.
February 19, 2024
 · 
2 min read
 · 
Tristan Manalac
Load More
PRESS RELEASES
Press Releases
Sensome Announces Positive First-in-Human Study Results for In Situ Tumor Detection Technology for Lung Cancer
May 19, 2026
 · 
5 min read
Press Releases
Lantern Pharma Announces Successful Outcome of FDA Type C Meeting Request for HARMONIC™ Phase 2 Trial of LP-300 in Never-Smokers with NSCLC
May 19, 2026
 · 
14 min read
Press Releases
Leads Biolabs’ PD-L1/4-1BB Bispecific Antibody Wins Pivotal Phase III Approval, Set to Reshape the Frontline Treatment Landscape for Advanced EP-NEC
May 19, 2026
 · 
6 min read
Press Releases
U.S. FDA Grants Priority Review to Supplemental New Drug Application for HYRNUO® (sevabertinib) Under Investigation as a First-Line Treatment of HER2-Mutated Non-Small Cell Lung Cancer
May 18, 2026
 · 
12 min read
Press Releases
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
May 17, 2026
 · 
7 min read
Press Releases
Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
May 17, 2026
 · 
14 min read
Press Releases
SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of ‘SNB-101'
May 14, 2026
 · 
2 min read
Press Releases
Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer
May 14, 2026
 · 
9 min read
Press Releases
DELFI Diagnostics to Present First Clinical Utility Data for Blood-Based Lung Cancer Screening at ATS 2026 International Conference
May 13, 2026
 · 
7 min read
Press Releases
Lung Cancer Research Foundation Grants Team Science Award Focused on Understanding and Treating Lung Cancers with HER2 Mutations
May 12, 2026
 · 
5 min read
Press Releases
Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research at ASCO 2026
May 12, 2026
 · 
19 min read
Press Releases
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy
May 11, 2026
 · 
2 min read
Press Releases
Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in Advanced ROS1-Positive Non-Small Cell Lung Cancer
May 6, 2026
 · 
11 min read
Press Releases
Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer
May 5, 2026
 · 
4 min read
Press Releases
Azra AI Acquires Thynk Health to Close the Gap Between Imaging and Cancer Care
April 28, 2026
 · 
6 min read
Press Releases
U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
April 28, 2026
 · 
11 min read
Press Releases
STUDY: CANCER PATIENTS EXPERIENCE LONGER SURVIVAL IN COMMUNITY ONCOLOGY SETTINGS
April 28, 2026
 · 
4 min read
Press Releases
Ivonescimab Receives Major Recommendations Across Multiple Therapies in the 2026 CSCO NSCLC Guideline
April 28, 2026
 · 
5 min read
Press Releases
Xcovery Partners with EVERSANA to Commercialize Lung Cancer Drug Ensacove in the U.S.
April 27, 2026
 · 
5 min read
Press Releases
Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (IBTROZI®) as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System Cancers
April 27, 2026
 · 
11 min read
Load More